Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135122
Status:
COMPLETED
Last Update Posted:
2008-09-12
First Post:
2005-08-24
Brief Title:
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
Sponsor:
Sorlandet Hospital HF
Organization:
Sorlandet Hospital HF
Study Overview
Official Title:
Medication Overuse Headache A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy Phase 3 and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether prednisolone is more effective than placebo in the first six days after initiation of medication withdrawal therapy for a medication overuse headache Another purpose is to study whether patients followed by a neurologist 1 year after withdrawal do better than patients followed by a general practitioner
Detailed Description:
Data published BoeMGMygland ASalvesen R Neurology 2007 Jul 369126-31
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None